Biliary clearance, total extrarenal clearance, body and renal clearance of inulin and iohexol were determined in 11 normal and 11 nephrectomized pigs. The biliary clearance of inulin, calculated as biliary excretion divided by the plasma concentration, was 0.04 and 0.01 ml min–1 10 kg–1 and of iohexol 0.21 and 0.1 ml min–1 10 kg–1 , in normal, respectively, nephrectomized pigs (p < 0.05). The extrarenal clearance of inulin, calculated as body minus renal clearance, was 2.7 and 0.7 ml min–1 10 kg–1 and of iohexol 3.7 and 0.7 ml min–1 10 kg–1 in normal, respectively, nephrectomized pigs (p < 0.05). Some hours after injection of the markers their plasma concentrations were much higher in the nephrectomized pigs. This higher plasma concentration was not matched by an equally higher biliary excretion and therefore biliary clearance decreased. The smaller total extrarenal clearance in nephrectomized pigs, i.e. the overestimation of GFR when calculated as body clearance, indicates that this source of error decreases with decreasing renal function.

1.
Smith H: The reliability of inulin as a measure of glomerular filtration; in: The Kidney – Structure and Function in Health and Disease. New York, Oxford University Press, 1951, pp 231–238.
2.
Bröchner-Mortensen J, Giese J, Rossing N: Renal inulin clearance versus total plasma clearance of 51CrEDTA. Scand J Clin Lab Invest 1969;23:301–305.
3.
Nosslin B: Determination of clearance and distribution volume with the single injection technique. Acta Med Scand 1965;(suppl 179):97–101.
4.
Bröchner-Mortensen J, Rödbro P: Comparison between total and renal plasma clearance of [51CR]EDTA. Scand J Clin Lab Invest 1976;36:247–249.
5.
Bröchner-Mortensen J, Freund LG: Reliability of routine clearance methods for assessment of the glomerular filtration rate in advanced renal insufficiency. Scand J Clin Lab Invest 1981;41:91–97.
6.
Rehling M, Möller ML, Thamdrup B, Lund JO, Trap-Jensen J: Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 1984;66:613–619.
7.
Jagenburg R, Attman P-O, Aurell M, Bucht H: Determination of glomerular filtration rate in advanced renal insufficiency. Scand J Urol Nephrol 1978;12:133–137.
8.
Becker JA, Gregoire A, Berdon W, Schwartz D: Vicarious excretion of urographic media. Radiology 1968;90:243–248.
9.
Nelson CMK, Brown RC, Culp DA: The extrarenal excretion of urographic contrast material. J of Urol 1973;110:109–110.
10.
Frennby B, Sterner G, Almén T, Chai CM, Jönsson BA, Månsson S: Extrarenal plasma clearance of iohexol, chromimum-51-ethylenediaminetetraacetic acid and inulin in anephric pigs. Acad Radiol 1996;3:145–153.
11.
Frennby B, Sterner G, Almén T, Chai CM, Jönsson BA, Månsson S: Clearance of iohexol, chromium-51-ethylenediaminetetraacetic acid and creatinine for determining the glomerular filtration rate in pigs with normal renal function: Comparison of different clearance techniques. Acad Radiol 1996;3:651–659.
12.
Frennby B, Sterner G, Almén T, Chai CM, Jönsson BA, Månsson S: Clearance of iohexol, 51Cr-EDTA and endogenous creatinine for the determination of glomerular filtration rate in pigs with reduced renal function: A comparison between different clearance techniques. Scand J Clin Lab Invest 1997;57:241–252.
13.
Frennby B: Use of iohexol clearance to determine Glomerular Filtration Rate. A Comparison between Different Clearance techniques in Man and Animal. Scand J Urol Nephrol 1997;31(suppl 182).
14.
Nossen JÖ, Jakobsen JÅ, Kjærsgaard P, Andrew E, Jacobsen PB, Berg KJ: Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with impaired renal function. Scand J Lab Invest 1995;55:341–350.
15.
Degenaar CP, Frenken LAM, v Hooff JP: Enzymatic method for determination of inulin. Clin Chem 1987;33:1070–1071.
16.
Morris AM, Elwood C, Sigman EM, Catanzaro A: The renal clearance of 131I labelled meglumine diatrizoate (Renografin) in man. J Nucl Med 1965;6:183–191.
17.
Blaufox M, Aurell M, Bubeck B, et al: Report of the Radionuclides in Nephrourology Committee on Renal Clearance. J Nucl Med 1996;37:1883–1890.
18.
Krutzén E, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P: Plasma clearance of a new contrast agent, iohexol: A method for the assessment of glomerular filtration rate. J Lab Clin Med 1984;104:955–961.
19.
Boijsen M, Jacobsson L, Tylén U: Renal function measured by X-ray fluorescence analysis: A comparison between contrast medium clearance and a non-simultaneous 51Cr-EDTA clearance. Acta Radiol 1987;28:581–585.
20.
Stake G, Monn E, Rootwelt K, Grönberg T, Monclair T: Glomerular filtration rate estimated by X-ray fluorescence technique in children: Comparison between plasma disappearance of 99mTc-DTPA and iohexol after urography. Scand J Clin Lab Invest 1990;50:161–167.
21.
Lundqvist S, Hietala SO, Berglund C, Karp K: Simultaneous urography and determination of glomerular filtration rate: A comparison of total plasma clearances of iohexol and 51Cr-EDTA in plegic patients. Acta Radiol 1994;35:391–395.
22.
Frennby B, Sterner G, Almén T, Hagstam KE, Hultberg B, Jacobsson L: The use of iohexol clearance to determine GFR in patients with severe chronic renal failure: A comparison between different clearance techniques. Clin Nephrol 1995;1:35–46.
23.
Stewart Cameron J, Greger R: Renal function and testing of function; in Oxford Textbook of Clinical Nephrology, ed 2. New York, Oxford University Press, 1998, vol 1, pp 39–54.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.